<DOC>
	<DOCNO>NCT01702701</DOCNO>
	<brief_summary>This study compare response treatment Eosinophilic Esophagitis montelukast vs standard therapy fluticasone . Investigators hypothesize montelukast equally effective treating symptom histology EoE compare fluticasone . The study conduct multiple site Medical College Wisconsin coordinate site . After identification recruitment patient randomize ( provider blind ) one two medication : montelukast 10mg po qday v fluticasone 440mcg po bid . Patients also complete pretreatment , 6 week therapy 12 week therapy questionaire . They undergo repeat endoscopy evaluate endoscopic histologic response .</brief_summary>
	<brief_title>Eosinophilic Esophagitis Treatment : Montelukast v Fluticasone</brief_title>
	<detailed_description>Eosinophilic esophagitis allergic condition esophagus incidence rise , limited treatment option . Current gold standard treatment topical steroid ( swallow fluticasone ) . There preliminary data oral montelukast may prove effective inducing maintain symptomatic along histologic remission disease . Investigators compare effectiveness singulair swallow fluticasone induce maintain histologic symptomatic remission eosinophilic esophagitis .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Patients confirm diagnosis EoE biopsy &gt; 15 eos per HPF age &gt; 18 Both male Female . Not pregnant pregnancy patient receive ongoing medical therapy EoE patient underwent dilation last 12 week improvement symptom LA grade B worse erosive esophagitis . age &lt; 18 nursing mother use prohibit concomitant medication : budesonideoral compound liquid , fluticasone montelukast .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>